Successful treatment of refractory adult-onset still disease with canakinumab: a case report

J Clin Rheumatol. 2014 Mar;20(2):121. doi: 10.1097/RHU.0000000000000082.

Authors

Simone Barsotti¹, Rossella Neri, Valentina Iacopetti, Anna d'Ascanio, Rosaria Talarico, Alessandra Tripoli, Stefano Bombardieri

Affiliation

¹ Rheumatology Unit Musculoskeletal Department University of Pisa Pisa, Italy simonebarsottipisa@gmail.com Rheumatology Unit Musculoskeletal Department University of Pisa Pisa, Italy Internal Medicine Barga, Italy Rheumatology Unit Musculoskeletal Department University of Pisa Pisa, Italy.

PMID: 24561423
DOI: 10.1097/RHU.0000000000000082

No abstract available

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents / therapeutic use*
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
Still's Disease, Adult-Onset / drug therapy*

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein